By shifting the focus from tumor associated mechanisms to intracochlear pathology, these findings pave the way for novel therapeutic strategies aimed at preserving cochlear integrity and improving auditory outcomes in patients with NF2-SWN. This evidence concerns the gene NF2 and neoplasm.